Search Results

QT Alterations in Psychopharmacology: Proven Candidates and Suspects

Authors: Alvarez, Paulino A.; Pahissa, Jaime

Source: Current Drug Safety, Volume 5, Number 1, January 2010 , pp. 97-104(8)

Publisher: Bentham Science Publishers

Other Drugs Acting on Nervous System Associated with QT-Interval Prolongation

Authors: Keller, Guillermo A.; Ponte, Marcelo L.; Di Girolamo, Guillermo

Source: Current Drug Safety, Volume 5, Number 1, January 2010 , pp. 105-111(7)

Publisher: Bentham Science Publishers

Pharmacotherapy for aggressive behaviours in persons with intellectual disabilities: treatment or mistreatment?

Author: Tsiouris, J. A.

Source: Journal of Intellectual Disability Research, Volume 54, Number 1, January 2010 , pp. 1-16(16)

Publisher: Blackwell Publishing

Overcoming the barriers experienced in conducting a medication trial in adults with aggressive challenging behaviour and intellectual disabilities

Authors: Oliver-Africano, P.; Dickens, S.; Ahmed, Z.; Bouras, N.; Cooray, S.; Deb, S.; Knapp, M.; Hare, M.; Meade, M.; Reece, B.; Bhaumik, S.; Harley, D.; Piachaud, J.; Regan, A.; Ade Thomas, D.; Karatela, S.; Rao, B.; Dzendrowskyj, T.; Lenôtre, L.; Watson, J.; Tyrer, P.

Source: Journal of Intellectual Disability Research, Volume 54, Number 1, January 2010 , pp. 17-25(9)

Publisher: Blackwell Publishing

Paliperidone palmitate - review of the efficacy, safety and cost of a new second-generation depot antipsychotic medication

Author: Citrome, L.

Source: International Journal of Clinical Practice, Volume 64, Number 2, January 2010 , pp. 216-239(24)

Publisher: Blackwell Publishing

Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies

Authors: Verdoux, H.; Tournier, M.; Bégaud, B.

Source: Acta Psychiatrica Scandinavica, Volume 121, Number 1, January 2010 , pp. 4-10(7)

Publisher: Blackwell Publishing

The prefrontal cortex: a target for antipsychotic drugs

Author: Artigas, F.

Source: Acta Psychiatrica Scandinavica, Volume 121, Number 1, January 2010 , pp. 11-21(11)

Publisher: Blackwell Publishing

Metabonomic studies of schizophrenia and psychotropic medications: focus on alterations in CNS energy homeostasis

Authors: Ma, Dan; Guest, Paul C; Bahn, Sabine

Source: Bioanalysis, Volume 1, Number 9, December 2009 , pp. 1615-1626(12)

Publisher: Future Science

Antipsychotic prescribing in nursing homes: an audit report

Author: Morrison, Anna

Source: Quality in Primary Care, Volume 17, Number 5, November 2009 , pp. 359-362(4)

Publisher: Radcliffe Publishing Ltd.

New review challenges antipsychotic use in dementia

Source: Reactions, Volume 1, Number 1279, 2009-11-21 , pp. 3-3(1)

Publisher: Adis International

Review of the operational definition for first-episode psychosis

Authors: Breitborde, Nicholas J. K.; Srihari, Vinod H.; Woods, Scott W.

Source: Early Intervention in Psychiatry, Volume 3, Number 4, November 2009 , pp. 259-265(7)

Publisher: Blackwell Publishing

A comparison of early psychosis treatment services using consensus and evidence-based performance measures: moving towards setting standards

Authors: Addington, Donald; Norman, Ross; Adair, Carol E.; Manchanda, Rahul; McKenzie, Emily; Mitchell, Beth; Pryce, Cathy

Source: Early Intervention in Psychiatry, Volume 3, Number 4, November 2009 , pp. 274-281(8)

Publisher: Blackwell Publishing

Who should swing the stethoscope? An audit of baseline physical examination and blood monitoring on new patients accepted by an early intervention in psychosis team

Authors: Crabb, Jim; McAllister, Mark; Blair, Alison

Source: Early Intervention in Psychiatry, Volume 3, Number 4, November 2009 , pp. 312-316(5)

Publisher: Blackwell Publishing

Proarrhythmic Risk with Antipsychotic and Antidepressant Drugs: Implications in the Elderly

Authors: Vieweg, W. Victor R.; Wood, Mark A.; Fernandez, Antony; Beatty-Brooks, Mary; Hasnain, Mehrul; Pandurangi, Anand K.

Source: Drugs & Aging, Volume 26, Number 12, 1 December 2009 , pp. 997-1012(16)

Publisher: Adis International

New review challenges antipsychotic use in dementia

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 592, 2009-11-28 , pp. 2-2(1)

Publisher: Adis International

Iloperidone: a new option for the treatment of schizophrenia

Author: Cutler, Andrew J

Source: Expert Review of Neurotherapeutics, Volume 9, Number 12, December 2009 , pp. 1727-1741(15)

Publisher: Expert Reviews

Ondansetron Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Preliminary, Single-Blind, Prospective Study

Authors: Pallanti, Stefano; Bernardi, Silvia; Antonini, Sarah; Singh, Nikhilesh; Hollander, Eric

Source: CNS Drugs, Volume 23, Number 12, 1 December 2009 , pp. 1047-1055(9)

Publisher: Adis International

Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials

Authors: McIntyre, Roger S; Muzina, David J; Adams, Amanda; Lourenco, Maria Teresa C; Law, Candy WY; Soczynska, Joanna K; Woldeyohannes, Hanna O; Nathanson, Jay; Kennedy, Sidney H

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 18, December 2009 , pp. 3061-3075(15)

Publisher: Informa Healthcare

Mechanisms of Action of Antipsychotic Drugs of Different Classes, Refractoriness to Therapeutic Effects of Classical Neuroleptics, and Individual Variation in Sensitivity to their Actions: PART I

Author: Miller, R.

Source: Current Neuropharmacology, Volume 7, Number 4, December 2009 , pp. 302-314(13)

Publisher: Bentham Science Publishers

Mechanisms of Action of Antipsychotic Drugs of Different Classes, Refractoriness to Therapeutic Effects of Classical Neuroleptics, and Individual Variation in Sensitivity to their Actions: PART II

Author: Miller, R.

Source: Current Neuropharmacology, Volume 7, Number 4, December 2009 , pp. 315-330(16)

Publisher: Bentham Science Publishers